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Background
China has the largest numbers of cancer patients world-
wide but has limited pathology resources. According to a
survey done by Chinese Pathologists Association, a large
number of pathologists in clinical practice in China has
only one year of formal or informal training. Only in
recent year, formal pathology residency programs similar
to those of Western countries are available in a couple of
large medical schools, where limited numbers of well-
trained and experienced pathologists are located. When
having rare or complex cancer pathology cases, patholo-
gists often have difficulty in making an accurate diagnosis.
Mistakes in cancer diagnosis are not uncommon, which
often leads to inadequate treatment of patients and
medical legal problems. Thus, there is a great need for
pathology consultation and quality control of cancer
diagnosis in China.
In recent years, telepathology or digital pathology has
been applied in many areas of pathology, including remote
consultation and quality control [1]. Difficult pathology
cases can be sent through internet or intranet to remote
site for consultation [2]. Quality control can be performed
on digitalized image or WSI by expert pathologists at
remote sites [3]. The practice of telepathology can solve
the problem of healthcare system with poor pathology
resource, especially in developing countries [4]. In order to
use pathology resource efficiently and to improve the
quality of pathology diagnosis of cancer, the Ministry of
Health of China developed and launched a nationwide
telepathology consultation and quality control program for
cancer diagnosis in China in 2011.
Designs
Internet platform
An internet based telepathology consultation platform
(http://www.mpathology.cn) was designed to serve as the
hub for the project, connecting hospitals and expert
consultants. Selection an internet based platform or a web-
site portal was due to the consideration that multiple
hospitals/institutions and multiple expert pathologists
from different institutions need to access the platform.
A server was used for storage of images and data. Figure 1
shows the flowchart of the platform.
For telepathology consultation, referring pathologists
from participating hospitals sent request for consults with
attached WSI and related clinical information to the inter-
net platform, the system would alert system information
technologists by e-mails. The technologists would then
check out the submitted materials to make sure the
requesting form is filled out appropriately with the WSI
attached. The system manager would then contact the
expert pathologist for consultation.
For quality control, a designated expert pathologist
would log into the platform, review the WSI of cancer
case from specific hospitals, assesses the accuracy of the
pathology diagnosis and quality of histology sections. The
results would then be sent to provincial and national
pathology quality control center.
All of the participating hospitals were supplied with a
virtual microscope, Motic Virtual Microscopic Scanner
(Motic Medical Diagnostic Systems Corporation, China).
The virtual microscope and related software were tested
and validated previously in a study involving a variety of
600 surgical pathology specimens in China. The study
showed a high concordance rate (94.2%) between WSI and
H/E glass slide [5].
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Expert consultants
356 pathologists with provincial and national reputation
volunteered to participate in the program. 80 of them were
selected to serve as expert consultants after passing an
online assessment consists of 30 pathology consultation
cases in WSI format. The names, affiliation of the patholo-
gists and the areas of their subspecialty expertise were
listed on the website (http://www.mpathology.cn). Experts
were provided with a unique identifier and access code to
the website. For telepathology consultation, the expert was
instantly informed by the cell phone message and e-mail
once he/she was requested for consult. The expert patholo-
gist would use a computer or an Ipad to log into the web-
site, check out the pending cases for consultation under
his/her name, review WSI of the case, capture a represen-
tative image from WSI to included in the final report, type
in pathologic features of the case, write up his/her opinion
and provide a final diagnosis. After that, he/she would pre-
view the final report, then sign the report with an electro-
nic signature and then release the final report.
Once the final consultation report was released, the
system sent an email to alert the system manager.
The final consultation report was then sent by the system
manger by e-mail or fax to the referring pathologist.
Participating hospitals
87 hospitals in 17 provinces where national healthcare
reform was carried out volunteered to participate the
phase I of the program, all of the hospitals had more than
6000 pathology cases annually. Pathologists in those
hospitals took an online diagnostic test of 50 cases of
cancer. Those hospitals having pathologists with excellent
test results were eliminated from the program. 60 hospitals
were finally selected to participate in the phase I of the
program. Participating hospitals were given a unique
identification code and user name to login to the website
platform. Pathologists of the participating hospitals are
required to receive a short period of training, which
includes operation of the virtual microscope and internet
connection to the platform. Storage and security of the
Figure 1 Nation-wide Telepathology consultation and quality control network. Figure 1 shows the flowchart of the internet platform and
nation wide network. Participating hospitals send digital images or WSI of the histology slides of cancer through the internet to the platform,
WSI is then stored in the server; expert pathologists from different institutions could access the website through the internet, review the WSI
stored in the server and deliver a second opinion or make an assessment of quality of pathology diagnosis.
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WSI, relevant clinical data, and consultation files are also
to be addressed.
For telepathology consultation, each participating
hospital is required to send WSI of at least 300 cases
annually for second opinion. The number of cases is set at
about 15% to 20% of cancer diagnosed each year in those
hospitals. Hospitals can choose pathologists for second opi-
nion or consultation from 80 expert consultants with
different subspecialty expertise. For quality control of
pathology diagnosis, the participating hospitals are required
to submit WSI of every cancer diagnosed to the platform.
Quality control is to be carried out by expert consultants
every 3 month on 10% randomly selected cases. The accu-
racy of cancer diagnosis and quality of tissue section are to
be reviewed, assessed, and submitted to provincial and
national pathology quality control centers. The results of
the phase I of the program are to be used to guide future
deployment of the program across the country.
Discussion and conclusion
Since 2009, due to the wide spread use of high speed
internet and availability of low cost virtual microscopes in
China, telepathology has gained attention from academic
institutions and government. In 2010, the Ministry of
Health of China released an announcement encouraging
hospitals to use telepathology for cancer diagnosis and
planned to develop a nationwide telepathology consulta-
tion service and quality control program. The plan is to
set up in each province a provincial telepathology consul-
tation and pathology quality control network, which
also connects to a central national network. The goal of
the plan is to facilitate remote consultation for cancer
diagnosis and to monitor the accuracy of pathological
diagnosis of cancer. In 2011, the phase I of the plan
consisting of 60 hospitals in 17 provinces was completed.
In China, we do not know the exact number of error in
pathological diagnosis of cancer, however, we believe the
rate is much higher than those reported in Western coun-
tries, as many pathologists in China are not as well trained
as those in Western countries and many pathologists in
China do not have subspecialty expertise. The project we
design asks participating hospitals to submit all of their
newly diagnosed cancer cases. 10% of those cases will be
randomly selected for review. The 10% is set arbitrarily and
is not a high percentage for newly diagnosed cancer cases,
in comparison to prospectively secondly review of all newly
diagnosed cancer cases or retrospective mandatory review
of all cancer cases by some institutions in North America.
Second opinion or consultation is extremely important
in pathology diagnosis, especially in cancer diagnosis. In a
retrospectively review of consultation cases of urological
malignancy, Wayment et al. [6] reported that a 10% dis-
agreement, of which 8% is major. Matasar et al. [7] review
the difference between second opinion and submitting
diagnosis in lymphoma cases and found that major diag-
nostic revision was 17.8% in 2001 and 16.4% in 2006. In
Asia or developing countries, the discrepancy rate is simi-
lar or much higher. In a review of 673 consultation cases
sent to a cancer center in Twain, Tsung [8] found a 16%
of major disagreement between original diagnosis and sec-
ond opinion. Hsu et al. [9] reported that among 2686 con-
sultation cases, the tentative diagnosis and consultation
diagnosis were discordant in 1,074 (64.3%) cases. Major
discrepancy was seen in 205 (12.3%) cases, of which 66.8%
were changed from malignant to benign, 21.0% were
changed from benign to malignant. Based on these studies,
the program we designed asks participating hospitals to
submit 10-20% of their cases for consultation.
Through this program, we believe that in near future
telepathology will be widely used in China for pathology
consultation and quality control. The program will not
only assists pathologists in dealing with diagnostically diffi-
cult pathology cases, but also benefits patients, who do not
need to travel a long distance to large hospitals for a sec-
ond opinion of cancer diagnosis, thus saving time and
money for patients. The program will also guaranty the
quality of pathology diagnosis of cancer in China.
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